As a pivotal component of the cyclin D-CDK4/6-Rb signaling pathway, CDK6 directly phosphorylates PFKP at S679 and PKM2 at S37, thereby increasing pentose phosphate metabolism and serine metabolism in tumor cells, elevating intracellular NADPH levels, and promoting tumor cell growth [22]. The gene discussed is PKM; the disease is neoplasm.